Dr. Georgia L. Wiesner is a Professor of Medicine at Vanderbilt University and has spent the majority of her career in the fast evolving area of cancer genetics. She serves as the founding Director of the Clinical and Translational Hereditary Cancer Program in the Vanderbilt-Ingram Cancer Center, a NCI designated comprehensive cancer center. Established in 2012, this program is devoted to the care of patients and families with an increased risk for cancer. To date, over 9000 patients have been evaluated in this program. Dr. Wiesner's research interests include family based studies and the translation of genetic tests into clinical care. She is the lead investigator for a funded project in the NCI Moonshot program to develop new precision oncology tools for cancer prevention. Her project will deploy and integrate a family history tool into the electronic medical record system. She is also an investigator in the eMERGE IV network, that is studying the impact of polygenic risk scores on clinical care.